	Pharmacogenomic predictors of anthracycline-induced cardiotoxicity in breast cancer patients: a systematic review and meta-analysis. Cardiooncology Bulusu VM, Shah B, Sawant S, Choudhary A, Das S, Jain S, Mallayasamy SR, Udupa KS, Arya N, Singh J, Rao M, Kanwar RK, Kumar A, Munisamy M. PMID: 41776629 [PubMed - as supplied by publisher]
	Advances in the study of pyrotinib for the treatment of HER2-positive breast cancer. Breast Cancer Res Li Y, Wang W, Liang Y, Lai H, Mi K, Zhang P, Zhang J, Wang Y. PMID: 41776549 [PubMed - as supplied by publisher]
	Circulating tumor cells (CTCs) enumeration and machine-learning based diagnostic biomarkers for breast cancer detection. BMC Cancer Liu CY, Lin YH, Tsai YF, Lu PY, Chen JL, Li YH, Huang CC, Lin YS, Chao TC, Feng CJ, Hsu CY, Chiu JH, Chen CM, Tseng LM. PMID: 41776447 [PubMed - as supplied by publisher]
	Gene driven analytical learning model for accurate breast cancer diagnosis. Sci Rep Hesham F, Abbassy MM, Abdalla M. PMID: 41776259 [PubMed - as supplied by publisher]
	Minimally invasive surgery for advanced-stage ovarian cancer: a review of evidence and emerging paradigms. Int J Gynecol Cancer Agusti N, Iniesta MD, Fagotti A, Rauh-Hain A. PMID: 41775564 [PubMed - as supplied by publisher]
	Challenging the standard in early-stage ovarian cancer: current evidence and a standardized framework for sentinel node mapping. Int J Gynecol Cancer Agusti N, Lago V, Nero C, Uccella S, Buda A, Chi D, Gardner G, Laven P, Rey I, Torné A, Fagotti A, Diaz-Feijoo B, Bizzarri N. PMID: 41775563 [PubMed - as supplied by publisher]
	De-escalation in stage IC epithelial ovarian cancer: adjuvant treatment. Int J Gynecol Cancer Dagher C, Jang M, Nasioudis D. PMID: 41775562 [PubMed - as supplied by publisher]
	Association Between Plant-Based Diet Index and Breast Cancer Risk Stratified by Menopausal and Hormone Receptor Status: A Case-Control Study Among Korean Women. J Korean Med Sci Lee J, Lee H, Gunathilake M, Jung SY, Kim J. PMID: 41775275 [PubMed - in process]
	Different exercise modalities and their effects on the inflammatory mediator repertoire in breast cancer survivors: A systematic review with Bayesian network meta-analysis and dose-response analysis. Eur J Oncol Nurs Yuan Y, Chen HB, Yuan Y, Chen BA, Xu SH, Yang QH, Zhang JH, Liu HR, Yang Z, Ban WK, Wang RC. PMID: 41775232 [PubMed - as supplied by publisher]
	Explainable machine learning framework for the molecular classification of triple negative breast cancer. Comput Methods Programs Biomed L BC, Patel T, Charan D, Sinha MG, S R, Jain M, Bhardwaj A, Gupta A, J D, K A, Mishra A, Mishra D. PMID: 41775141 [PubMed - as supplied by publisher]
	Association of body mass index and length of stay in patients undergoing minimally invasive surgery for uterine cancer: a National Surgical Quality Improvement Program (NSQIP) study. Int J Gynecol Cancer Benseler A, Gien LT, Swift B, Covens A, Vicus D. PMID: 41774951 [PubMed - as supplied by publisher]
	Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer. Mol Pharm Ta, Schäfer M, Shuja-Uddin A, Bauder-Wüst U, Kovacs Dos Santos L, Bartnitzky L, Oden F, Platzk M, König T, Rüther PL, Pook E, Dvo, Nový Z, Pet, Hagemann UB, Bene. PMID: 41774810 [PubMed - as supplied by publisher]
	Unraveling the Î±VÎ²5-GLUT5 axis in breast cancer: linking extracellular matrix signaling to fructose metabolism: a scoping review. Mol Biol Rep Tade RS, Pawara DL, Patil PO, Patil PB. PMID: 41774272 [PubMed - in process]
	Identifying hormone receptor-positive breast cancer subtypes with recurrence scores derived from pathological data without Ki-67 indices: a clinicopathological study of breast cancer survival in West Asia. Virchows Arch Hughson MD, Majid RA, Mohammed HA, Hassan RO, Muhealdeen DN, Hassan HA. PMID: 41774182 [PubMed - as supplied by publisher]
	ChatGPT Versus DeepSeek for Breast Cancer Information Retrieval: Quantitative Comparative Study. JMIR Cancer Hajjo R, Sabbah DA, Bardaweel SK. PMID: 41773687 [PubMed - in process]
	Educational Intervention to Improve Sexual Health and Quality of Life in Survivors of Breast and Gynecological Cancer: Protocol for a Mixed Methods Feasibility Study. JMIR Res Protoc Salazar Falla N, Navas Jojoa MLÁ, Lalinde Riviño JD, Escandón Bucheli A, Galindo-Sánchez JS. PMID: 41773666 [PubMed - in process]
	Nanotechnology based targeted drug delivery systems for breast cancer: challenges, recent advancement and future perspectives. Nanomedicine (Lond) Kumar S, Rathaur S, Maity D, Varshney P, Gayen JR. PMID: 41773625 [PubMed - as supplied by publisher]
	The Role of Ki-67 in Predicting Breast Cancer Survival in Indonesia: A Prospective Cohort Study. Clin Ter Yarso KY, Azmiardi A, Ardianti M, Wahyudi AZ. PMID: 41773376 [PubMed - in process]
	Interplay of iron regulatory proteins and inflammatory markers in benign and malignant ovarian cancer: A cross sectional study. Clin Ter Haritha Padannapurath M, Sudha K, Neelam MP, Sowndarya K. PMID: 41773365 [PubMed - in process]
	"Methodological Constraints and Interpretive Overreach in ESR1-Breast Cancer Association Studies: A Critical Appraisal". Health Sci Rep Tahir I, Shahbaz H. PMID: 41773216 [PubMed]

Articles 1 - 20 / 325086

Page 1 of 16255



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy